USPTO serial 76300711
V VETTER
Reviewed by CopyMark Law Group
Reg. 3036124Status 710
- Filing date
- Status date
- Registration date
- Dec 27, 2005
- Examiner
- BUSH, KAREN K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with V VETTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
D-88212 Ravensburg, DE
Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
D-88212 Ravensburg, DE
Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
D-88212 Ravensburg, DE
Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Herbert Dubno
HERBERT DUBNO THE FIRM OF KARL F ROSS, PC5676 RIVERDALE AVE # 900BRONX, NY 10471-2138UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and medicaments, solutions for oral use, sterile solutions in forms suitable for sale and/or for application and solutions for injections; all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders, and preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinse, factor VIII, gnrh analogs, and recombinant proteins eye drops, solutions for contact lenses; fillings of liquid, semi-solid or solid substances, namely pharmaceutical products in solvated form as solutions with active agents, as powders with solvent or as lyophilistates with solvent in injection systems, namely, in injection syringes and instruments for infections, injectors, injector pens as well as in single chamber, double chamber and disposable syringes, as well as solutions for oral use as well as sterile solutions suitable for sale and /or for application, solutions for injections including aseptic filling of injection solutions all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders, and preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinase, factor VIII, gnrh analogs, and recombinant proteins, manufactured objects and products for medical and medical-technical use, namely tampons with and without disinfectants and bandages separately or jointly packed, and in sterile packages | SECTION 8 - CANCELLED | Sep 25, 2003 |
| 007 | Machine tools, motors, couplings and clutches, drive belts, filling machines, labelling machines packaging machines, box-making machines for erecting, filling and closing of cardboard and foldable boxes; machines for washing, filling and closing containers, namely medical syringes and vials, robots, mechanical transport machines for the transfer of containers between processing stations, and thermoforming machines for producing, filling and sealing of blister packaging; and machines for controlling the supply and filling of goods in containers | SECTION 8 - CANCELLED | Sep 25, 2003 |
| 010 | Medical injection systems, namely syringes and instruments for injections, injectors, injection pens auto-injectors as well as single chamber and double chamber disposable syringes, all sold empty, containers for medicaments made from glass and/or plastics and syringe holders for ready-to-use syringes for picking-up and handling of syringes | SECTION 8 - CANCELLED | Sep 25, 2003 |
| 042 | Development of injection syringes and instruments and injectors and corresponding packages; chemical, physical and procedural examinations as well as microbiological examinations also as paid service for third parties | SECTION 8 - CANCELLED | Sep 25, 2003 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
- Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
- Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named V VETTER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 3, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 27, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 16, 2005 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Nov 10, 2005 | ALIE | ASSIGNED TO LIE | — |
| Nov 9, 2005 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 17, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 3, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2005 | PAPER RECEIVED | — | |
| Mar 31, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2005 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2004 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 8, 2004 | IUAF | USE AMENDMENT FILED | — |
| Oct 8, 2004 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 20, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 16, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 7, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 7, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 15, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 7, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 7, 2003 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 8, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 14, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 25, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 12, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 15, 2002 | 44DD | SEC. 44(D) CLAIM DELETED | — |
| Oct 15, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 15, 2002 | PAPER RECEIVED | — | |
| Apr 17, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Dec 6, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2001 | DOCK | ASSIGNED TO EXAMINER | — |